Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 6145651, 13 pages
https://doi.org/10.1155/2017/6145651
Research Article

The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats

1Department of Ophthalmology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2Department of Cardiac Surgery, Institute of Cardiovascular Diseases of Fudan University, Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
3DMPK & Bioanalysis Department Sundia MediTech Company, Shanghai, China
4Department of Ophthalmology, Shanghai Tenth People’s Hospital, Shanghai, China
5Department of First Clinical Medical College, Nanjing Medical University, Nanjing, China
6Department of Ophthalmology, Shanghai Tenth People’s Hospital, Nanchang University, Nanchang, China

Correspondence should be addressed to Jing Yu; moc.nuyila@gnijuyrd

Received 4 January 2017; Revised 3 April 2017; Accepted 27 August 2017; Published 22 October 2017

Academic Editor: Lisa Toto

Copyright © 2017 Chengda Ren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Chengda Ren, Hui Shi, Juanjuan Jiang, et al., “The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats,” Journal of Ophthalmology, vol. 2017, Article ID 6145651, 13 pages, 2017. https://doi.org/10.1155/2017/6145651.